Abstract:Background Rapid proliferation and glucose metabolism remodeling are hallmarks of cancers. Long non-coding RNAs (lncRNAs) are potentially involved in Warburg effect. We aimed to identify oncogenic lncRNAs that significantly affect the development of esophageal squamous cell carcinoma (ESCC) and investigate the metabolism-related mechanisms. Methods Bioinformatics analysis and siRNA library screening were used to pinpoint lncRNAs that significantly affected cell glycolysis and proliferation. RNAScope(R) in situ hybridization and qRT-PCR assays were performed in clinical samples to investigate expression levels and clinical relevance of the lncRNA. RNA interference and CRISPR-Cas9 were used to explore the functional roles of the lncRNA. In vivo, cell-based and patient-derived xenograft (PDX) models were used. Extracellular acidification rate and 13C-labeled intracellular metabolites were determined. RNA pull-down, MS2-Tagged RNA affinity purification, RNA-binding protein immunoprecipitation and cross-linking immunoprecipitation were performed to identify lncRNA associated proteins and related mechanisms. Results The lncRNA LOC148709 was identified as a metabolism-related lncRNA. Increased expression of LOC148709 was observed in ESCC and was correlated with poor prognosis. LOC148709 knockdown significantly decreased cell proliferation and glycolysis. Mechanistically, LOC148709 was directly associated with PFKFB3 and significantly affected PFKFB3 stability. LOC148709 interacted mainly with the C-terminal fragment of PFKFB3 and the T5 (2031–2321) fragment of LOC148709 mediated the interaction with PFKFB3. Through inhibiting K302 ubiquitination, LOC148709 protected PFKFB3 from proteasomal degradation, which subsequently activated glycolytic flux and promoted cell cycle progression by regulating p27 and CDK1. P53 could bind to the LOC148709 promoter and repress its transcription, p53 loss or mutation triggered striking LOC148709 upregulation. Multiple micro-environmental factors, including hypoxia and oncogenic stress, were also involved in the LOC148709 regulatory network via affecting the status of p53. Notably, our patient-derived xenograft (PDX) model studies demonstrated that LOC148709 knockdown dramatically impaired tumor growth. Conclusions The lncRNA LOC148709 plays an essential role in glycolytic reprogramming by binding to and stabilizing PFKFB3. This study identified a novel metabolism-related lncRNA and revealed a novel mechanism underlying lncRNA-mediated cancer metabolism remodeling. Translational studies further implicated that LOC148709 is a promising biomarker for cancer diagnosis and therapy.

Glycolysis reprogramming in cancer-associated fibroblasts promotes the growth of oral cancer through the lncRNA H19/miR-675-5p/PFKFB3 signaling pathway

Abstract 2389: LINC00901 Regulates Glucose Metabolism in Pancreatic Cancer

Linc00901 Regulates Glucose Metabolism In Pancreatic Cancer.

Long Noncoding RNA AGPG Regulates PFKFB3-mediated Tumor Glycolytic Reprogramming

lncRNA CYTOR promotes aberrant glycolysis and mitochondrial respiration via HNRNPC-mediated ZEB1 stabilization in oral squamous cell carcinoma

TGF-βRII Regulates Glucose Metabolism in Oral Cancer-Associated Fibroblasts Via Promoting PKM2 Nuclear Translocation.

Glycometabolic Reprogramming-Mediated Proangiogenic Phenotype Enhancement of Cancer-Associated Fibroblasts in Oral Squamous Cell Carcinoma: Role of PGC-1α/PFKFB3 Axis.

IDDF2019-ABS-0200 Long Non-Coding RNA LOC148709 Regulates PFKFB3-mediated Glycolytic Reprogramming in Esophageal Squamous Cell Carcinoma

Long noncoding RNA LINC00930 promotes PFKFB3-mediated tumor glycolysis and cell proliferation in nasopharyngeal carcinoma

Cancer-Associated Fibroblasts Contribute to Oral Cancer Cells Proliferation and Metastasis Via Exosome-Mediated Paracrine MiR-34a-5p

Loss of MiR-192-5p Initiates a Hyperglycolysis and Stemness Positive Feedback in Hepatocellular Carcinoma.

Metabolic Reprogramming of Normal Oral Fibroblasts Correlated with Increased Glycolytic Metabolism of Oral Squamous Cell Carcinoma and Precedes Their Activation into Carcinoma Associated Fibroblasts.

Tumoral Microvesicle–activated Glycometabolic Reprogramming in Fibroblasts Promotes the Progression of Oral Squamous Cell Carcinoma

Cancer-associated fibroblasts promote tumor progression by lncRNA-mediated RUNX2/GDF10 signaling in oral squamous cell carcinoma

LINC01554-Mediated Glucose Metabolism Reprogramming Suppresses Tumorigenicity in Hepatocellular Carcinoma via Downregulating PKM2 Expression and Inhibiting Akt/mTOR Signaling Pathway

Data from Long Noncoding RNA LINC00092 Acts in Cancer-Associated Fibroblasts to Drive Glycolysis and Progression of Ovarian Cancer

Long Non-Coding RNA UCA1 Promotes Glycolysis by Upregulating Hexokinase 2 Through the Mtor-Stat3/microrna143 Pathway.

LncRNA FENDRR in Carcinoma-Associated Fibroblasts Regulates the Angiogenesis of Oral Squamous Cell Carcinoma Through the PI3K/AKT Pathway

PO-364 LncRNA-P23154 Promotes the Invasion-Metastasis Potential of Oral Squamous Cell Carcinoma by Regulating Glut1-mediated Glycolysis

IDDF2018-ABS-0184 LNCRNA AGPG Regulates Anabolism Remodelling Through Affecting PFKFB3 Stability in Escc